Tivic Health Systems, Inc.
TIVC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | 0.04 | 0.01 | 0.01 |
| FCF Yield | -37.99% | -50.50% | -58.23% | -241.96% |
| EV / EBITDA | -0.15 | -1.28 | -0.57 | 1.13 |
| Quality | ||||
| ROIC | -44.41% | -52.45% | -49.60% | -60.87% |
| Gross Margin | -99.32% | 62.79% | 71.43% | -132.78% |
| Cash Conversion Ratio | 0.77 | 0.95 | 0.59 | 0.92 |
| Growth | ||||
| Revenue 3-Year CAGR | -26.76% | -31.25% | -33.93% | -24.89% |
| Free Cash Flow Growth | 21.49% | -107.76% | 34.87% | 2.99% |
| Safety | ||||
| Net Debt / EBITDA | 1.39 | 0.61 | 0.44 | 1.58 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.11 | 0.07 | 1.31 |
| Cash Conversion Cycle | 11.71 | 151.42 | -577.29 | 76.17 |